Tempus Capital Inc. (CSE: TEMP) and TUK Group Close New Toronto Development Project With Additional Sites Under Contract

About Tempus Capital Inc. Tempus Capital Inc. is a Canadian real estate company engaged in the acquisition, development and ownership of income-generating properties. Tempus trades on the Canadian ...

Tempus Capital Inc.: Tempus Capital Announces Joint Development Project in Toronto with TUK Group

Tempus Capital Inc. (CSE: TEMP) ("Tempus" or the "Company") is pleased to announce it has signed a joint development with TUK Group for a new ...
Nasdaq

A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced its participation in almost ...

Is Tempus AI, Inc. (TEM) a good stock to buy now?

We came across a bullish thesis on Tempus AI, Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the ...
Business Wire

Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to develop a ...
Seeking Alpha

Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new strategic collaboration to ...
Business Wire

Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley ...
Morningstar

Northwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, Into Its EHR Platform

Tempus’ generative AI-enabled clinical assistant is designed to support providers in unlocking new insights and efficiencies Northwestern Medicine and Tempus AI, Inc. (NASDAQ: TEM) today announced a ...
Nasdaq

Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer

Tempus Next supports providers in closing gaps in care for eligible patients based on clinical guidelines. “Staying current with rapidly evolving clinical guidelines—especially regarding biomarker ...
Seeking Alpha

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects ...